By Will Boggs, MD NEW YORK (Reuters Health) – Temsirolimus does not improve progression-free survival in metastatic renal cell carcinoma (RCC) compared to standard treatment, according to results…
NEW YORK (Reuters Health) – In patients with potentially resectable colorectal liver metastases, the use of combined PET and CT imaging (PET-CT) identifies those with occult extrahepatic disease…
Recent Videos in Reuters Health • The Doctor’s Channel Newscast Page 173
NEW YORK (Reuters Health) – Patients with macroprolactinemia don’t need extensive exams or prolonged monitoring, according to a prospective study. As long as their monomeric prolactin concentration is…
NEW YORK (Reuters Health) – A single yearly oral dose of 500,000 international units of cholecalciferol (vitamin D) does not protect generally healthy older women from falls and…
NEW YORK (Reuters Health) – The dopamine agonist pramipexole relieves depressive symptoms in patients with Parkinson’s disease, according to a study published online May 10th in The Lancet…
NEW YORK (Reuters Health) – Mounting evidence suggests that preoperative prostate specific antigen (PSA) kinetics are a poor marker of disease progression. During active surveillance for low-risk, low-volume…
NEW YORK (Reuters Health) – An iPhone with dedicated software for evaluation of coronary CT angiography (CTA) is highly accurate for detecting and excluding significant stenosis, according to…
NEW YORK (Reuters Health) – When colonoscopy is scheduled for the afternoon, drinking the electrolyte solution in the morning is clinically equivalent to drinking half of it the…
NEW YORK (Reuters Health) – Low-intensity extracorporeal shockwave therapy (LI-ESWT) can improve erectile function, according to a pilot study from Israel. Twice a week for 3 weeks, 20…
NEW YORK (Reuters Health) – Dizziness in the elderly is caused by cardiovascular disease in over half of patients seen in primary care, according to new research from…
NEW YORK (Reuters Health) – Pegylated interferon alfa-2a safely reduces HIV-1 load in untreated patients without chronic hepatitis C virus (HCV) infection, according to a report in the…
NEW YORK (Reuters Health) – Intravesical botulinum toxin improves overactive bladder symptoms, but with a significant risk of urinary retention, according to a meta-analysis reported April 19th in…
